“Honey, We Shrunk the Curve!”
By Jonathan Carson, PhD and Jon A. Rowley, PhD, with acknowledgement to scientists who sounded the alarm like Dr. Liz Specht and to all health workers on the front lines. ... More
Cell Therapy
Can MSCs Treat Patients with COVID-19?
Authored by Mayasari Lim | West Coast and APAC lead for RoosterBio Amidst the scramble and panic-buying that some of us are experiencing, several treatments to combat this novel ... More
Scalable MSC Manufacturing Matters in a Rapid Response to COVID-19
Authored by: Jon Carson, Iain Farrance, John Getz, and Jon A. Rowley, RoosterBio, Inc. On 31-December-2019, Chinese officials alerted the World Health Organization of an outbreak of pneumonia cases in ... More
Advances in Clinical Translation and Scale-up of MSCs and Extracellular Vesicles at ISCT 2019
Authored by Katrina Adlerz, Ph.D., Scientist, Analytics, Product & Process Development & Josephine Lembong, Ph.D., Scientist, Analytics, Product & Process Development The 2019 International Society for Cell and Gene Therapy (ISCT) ... More
RoosterBio Products Continue to Expand Presence in Major Mesenchymal Stem/Stromal Cell (MSC)-related Regenerative Medicine Peer Reviewed Publications
Authored by Joseph Candiello, Ph.D., Technical Application Specialist Human Mesenchymal Stem/Stromal Cells (hMSCs) are a critical starting material in a growing variety of established and emerging applications spanning the Regenerative ... More
ISCT 2018: MSC Biomanufacturing, Bioprocessing, Scale-Up, Analytics and Exosome Production Take Center Stage
Authored by Katrina Adlerz, Ph.D. Scientist, Analytical Development, RoosterBio Inc. RoosterBio attended the International Society for Cell Therapy annual meeting, held May 2-5, 2018 in Montreal, which brought together leaders ... More
Towards a Cell Therapy Manufacturing Technology Roadmap — Resources
RoosterBio was founded to accelerate the development of the Regenerative Medicine field by utilizing advancements in Manufacturing Sciences. As such, we have long been involved in laying the groundwork for a Technology ... More
The Use of Animal Serum in the Clinical Translation of hMSCs
Human mesenchymal stem or stromal cells (hMSCs) are an integral part of cell-based therapeutics, with over 400 clinical trials recently completed or in progress using hMSCs. As more research teams ... More
NIST Workshop Aims to Educate on Improving Confidence in Measurements Critical for Cell Therapy Products
We are always looking for ways to enable the commercialization of Cell-based Therapy and Technology. The ultimate success of the field is dependent on the convergence of several technology fields, ... More
How Quickly are Cell-based Products Really Developing? Thoughts from the IBC Cell Therapy Bioprocessing Conference
Last week was the 4th Annual IBC Cell Therapy Bioprocessing Conference. IBC (home of the BioProcess International conference) was the first conference organizer to dedicate a focused meeting on Cell Therapy Manufacturing Technologies 4 ... More